Clinical Trial

TDM Guided Early Optimization of ADAL in Crohn's Disease

Study Description

TDM Guided Early Optimization of ADAL in Crohn's Disease

To investigate the influence of early therapeutic drug monitoring and dose optimization on disease outcome in Crohn's patients treated with Adalimumab.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Recruiting patients only Recruiting patients only

Biological - Adalimumab

Additional Information

Official Study Title

Therapeutic Drug Monitoring Guided Early Optimization of Adalimumab in Crohn's Disease; A Randomized Open Label Study

Clinical Trial ID

NCT03261102

ParticipAid ID

mbk4xd